Did ATOMIC really improve on the standard of care for mismatch repair-deficient colon cancer?

Competing interests

J.-D.B.-F. declares no competing interests. B.G. has acted as a consultant of Vivio Health. D.K. has acted as an advisor of Lutris, MSD, Roche and Takeda, and has received speaker’s fees from Abbvie and AstraZeneca.

Comments (0)

No login
gif